The global Acarbose market was valued at US$ 142.8 million in 2022 and is projected to reach US$ 171.9 million by 2029, at a CAGR of 2.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Acarbose market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Acarbose market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Acarbose market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Acarbose is a kind of API that is white powder,It is used to product such as acarbose tablets/acarbose capsules/acarbose chewable tablets?which is a kind of? - glucosidase inhibitor procucts. The medicine used drugs for type 2 diabetes, which is a pseudo-four sugar biosynthesis, can inhibit the small intestine cells activity of ? - glucosidase, thereby delaying intestinal oligosaccharide, disaccharide or polysaccharide degradation, delaying the degradation and absorption of glucose and fructose in order to achieve the effect of reducing postprandial blood glucose.
This report aims to provide a comprehensive presentation of the global market for Acarbose, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acarbose. This report contains market size and forecasts of Acarbose in global, including the following market information:
- Global Acarbose Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Acarbose Market Sales, 2018-2023, 2024-2030, (M Pcs)
- Global top five Acarbose companies in 2022 (%)
China is the largest Acarbose market with about 71% market share. Korea is follower, accounting for about 12% market share.
The key players are Bayer, CKDBioCorporation, Hangzhou East China Pharmaceutical, Livzon Pharmaceutical Group, Hebei Huarong Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhebei Pharmaceutical etc. Top 3 companies occupied about 83% market share.
We surveyed the Acarbose manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acarbose Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (M Pcs)
Global Acarbose Market Segment Percentages, by Type, 2022 (%)
- 100 Mg Tablet
- 25 Mg Tablet
- 50 Mg Tablet
Global Acarbose Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (M Pcs)
Global Acarbose Market Segment Percentages, by Application, 2022 (%)
- Type II Diabetes
- Type I Diabetes
- Low Glucose Tolerance
- Other
Global Acarbose Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (M Pcs)
Global Acarbose Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Acarbose revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Acarbose revenues share in global market, 2022 (%)
- Key companies Acarbose sales in global market, 2018-2023 (Estimated), (M Pcs)
- Key companies Acarbose sales share in global market, 2022 (%)
key players include:
- Mitsubishi
- Amneal Pharmaceuticals
- Bayer
- Mayne Pharma
- Alvogen
- Strides Pharma
- Heritage Pharmaceuticals
- PD-Rx Pharmaceuticals
- Empros Pharma
- Lotus Pharmaceutical
- Esteve Pharma
- Wockhardt
- Green Leaf Pharmaceutical
- East China Pharmaceutical
- Beijing Yangguang Nuohe Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acarbose, market overview.
Chapter 2: Global Acarbose market size in revenue and volume.
Chapter 3: Detailed analysis of Acarbose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acarbose in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Acarbose capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
